Back to results
US 2012/0083471 A1Published application
Novel Compounds, Pharmaceutical Compositions Containing Same, Methods of Use for Same, and Methods for Preparing Same
OwnerCraig A. Townsend, Edward Wydysh +2inventors
InventorsCraig A. Townsend, Edward Wydysh, Francis Kuhajda, Gabriele Valeria Ronnett
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel pharmaceutical compositions containing the same, and methods of use for a variety of therapeutically valuable uses including, but not limited to, treating obesity by inhibiting the activity of Glycerol 3-phosphate acyltransferase (GPAT).
Claims24
-58. (canceled)
A compound comprising a formula I:
- wherein
- n is either 0 or 1;
- A is selected from the group consisting of NR1, O, and S, wherein le is selected from the group consisting of H, hydroxyl, C1-C10 alkyl, C1-C10 alkoxy, alkenyl, aryl, alkylaryl and arylalkyl;
- X is selected from the group consisting of a carboxylate residue, a phosphonate residue, a phosphate residue, and a C1-C10 alkyl residue which is optionally substituted with one or more residues selected from the group consisting of a carboxylate residue, a phosphonate residue and a phosphate residue;
- Y is selected from the group consisting of C1-C20 alkyl, alkenyl, halide, hydroxyl, C1-C20 alkoxy, aryl, alkylaryl, arylalkyl, cycloalkyl, cycloalkenyl and a heterocyclic ring, any of which are optionally substituted at one or more positions with a halogen;
- and
- Z is selected from the group consisting of H, a hydroxyl group, a halide, an aryl group, an alkylaryl group, an arylalkyl group, a cycloalkyl group, a cycloalkenyl group and a heterocyclic ring, any of which are is optionally substituted at one or more positions with one or a combination of substitution groups selected from the group consisting of a C1-10 alkyl group, C1-10 alkoxy group, a hydroxyl group, a cyano group, a carboxylate group, a halide, an aryl group, an alkylaryl group, an arylalkyl group, a cycloalkyl group, a cycloalkenyl group and a heterocyclic ring.
4 more elements
A compound comprising a formula IVa:
- wherein
- n is 0;
- A is selected from the group consisting of NR1, O, and S, wherein R1 is selected from the group consisting of H, hydroxyl, C1-C10 alkyl, C1-C10 alkoxy, alkenyl, aryl, alkylaryl and arylalkyl;
- Y is selected from the group consisting of C1-C20 alkyl, alkenyl, halide, hydroxyl, C1-C20 alkoxy, aryl, alkylaryl, arylalkyl, cycloalkyl, cycloalkenyl and a heterocyclic ring, any of which are optionally substituted at one or more positions with a halogen;
- and
- Z is selected from the group consisting of H, a hydroxyl group, a halide, an aryl group, an alkylaryl group, an arylalkyl group, a cycloalkyl group, a cycloalkenyl group and a heterocyclic ring, any of which are optionally substituted at one or more positions with one or a combination of substitution groups selected from the group consisting of a C1-10 alkyl group, C1-10 alkoxy group, a hydroxyl group, a cyano group, a carboxylate group, a halide, an aryl group, an alkylaryl group, an arylalkyl group, a cycloalkyl group, a cycloalkenyl group and a heterocyclic ring.
3 more elements
Dependencies are inferred from the claim text.